Amgen Inc. Intellectual Property Contracts & Agreements

19 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to Exclusive License and Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
2022
Amendment No. 2 to Exclusive License and Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
2017
Amendment No. 1 to Exclusive License and Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
2017
Exclusive License and Collaboration Agreement between Amgen Inc. and Novartis Pharma AG (August 28, 2015)
License Agreements
Amgen Inc.
Biotechnology
CA
2017
Amendment No. 2 to License Agreement between Amgen Inc. and Takeda Pharmaceutical Company Limited
License Agreements
Amgen Inc.
Biotechnology
CA
2013
Amendment No. 1 to License Agreement between Amgen Inc. and Takeda Pharmaceutical Company Limited
License Agreements
Amgen Inc.
Biotechnology
CA
2013
License Agreement for Motesanib Diphosphate Between Amgen Inc. and Takeda Pharmaceutical Company Limited (February 1, 2008)
License Agreements
Amgen Inc.
Biotechnology
CA
2008
Multi-Product License Agreement Between Amgen Inc. and Takeda Pharmaceutical Company Limited (Japan)
License Agreements
Amgen Inc.
Biotechnology
CA
2008
Amendment No. 4 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 3 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 2 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 1 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 2 to G-CSF United States License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 1 to G-CSF United States License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
G-CSF United States License Agreement between Kirin-Amgen, Inc. and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
CA
2001
G-CSF European License Agreement between Kirin-Amgen, Inc. and Amgen, Inc. (December 30, 1986)
License Agreements
Amgen Inc.
Biotechnology
CA
2001
Assignment and License Agreement between Amgen and Kirin-Amgen, Inc. (July 1, 1986)
License Agreements
Amgen Inc.
Biotechnology
CA
2001
Product License Agreement between Kirin-Amgen, Inc. and Ortho Pharmaceutical Corporation (Erythropoietin)
License Agreements
Amgen Inc.
Biotechnology
CA
2000
Product License Agreement between Amgen and Ortho Pharmaceutical Corporation
License Agreements
Amgen Inc.
Biotechnology
CA
2000